Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Maravai LifeSciences Holdings Inc. Class A Common Stock (MRVI) vs VF Corp (VFC) Price & Performance

Maravai LifeSciences Holdings Inc. Class A Common StockTrade

Price performance (Past 24H)

Key statistics

Maravai LifeSciences Holdings Inc. Class A Common Stock vs VF Corp — how do they compare? Maravai LifeSciences Holdings Inc. Class A Common Stock trades at $6.56 (market cap $972.90M), while VF Corp trades at $16.52 (market cap $6.32B). The key difference: VF Corp is far larger — about 6.5× Maravai LifeSciences Holdings Inc. Class A Common Stock's market cap, and VF Corp pays a 2.24% dividend while Maravai LifeSciences Holdings Inc. Class A Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Maravai LifeSciences Holdings Inc. Class A Common Stock for 0 Days and VF Corp for 64 Days on average.

MRVIVFC
Market Cap
$972.90M$6.32B
Volume
4,325,71014,983,623
Sector
HealthConsumer Cyclical
52-Week High
$9.00$21.55
52-Week Low
$2.83$12.62
Typical Hold Time
0 Days64 Days
Enterprise Value
$1.08B$10.60B
Dividend Yield
—2.24%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Maravai LifeSciences Holdings Inc. Class A Common Stock

Maravai LifeSciences (MRVI) trades at $6.53, down 7.51% in the last session amid mixed signals. The stock shows improving fundamentals with Q2 2026 revenue growth of 9% and three consecutive earnings beats, though it remains unprofitable with a -37.07% net margin. Technical analysis indicates neutral positioning with key support at $6 and resistance at $7. Recent news highlights patent expansions in China and institutional accumulation.

The outlook remains cautiously optimistic with analyst consensus pointing to 7% upside potential to the $7.00 price target. Key opportunities include margin expansion and RNA technology leadership, while risks center on persistent cash burn and competitive pressures in life sciences. The stock offers speculative growth potential for risk-tolerant investors.

VF Corp

VFC trades at $16.48, up 4.37% today, with a bullish technical signal and a consensus analyst price target of $18.33. Recent earnings show mixed results, with a Q4 2025 beat but Q1 and Q2 2026 misses. Revenue declined to $9.5B in 2025, with a net loss of $189.72M, though 2026 projects a return to profitability. The company maintains a strong gross margin of 54.97% but faces challenges from high debt and weak performance in its Vans brand.

The outlook is cautiously optimistic, supported by valuation discounts (P/S 0.67) and growth in outdoor brands, but execution risk on the Vans turnaround and high leverage pose significant threats. Near-term price action is buoyed by technical momentum, yet fundamental recovery hinges on sustained revenue improvement and debt reduction.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

MRVI
100% Buy0% Sell
Avg holding period · 0 Days
VFC
17% Buy83% Sell
Avg holding period · 64 Days

Top news

Latest headlines on both assets

About Maravai LifeSciences Holdings Inc. Class A Common Stock

Maravai LifeSciences Holdings Inc. is a life sciences company supporting drug therapy, diagnostic, and vaccine development through four operating brands: TriLink BioTechnologies (nucleic acid and mRNA synthesis), Cygnus Technologies (biologics safety testing), Glen Research (oligonucleotide synthesis materials), and Alphazyme (enzyme manufacturing). It serves biotech and biopharma customers from discovery through commercial manufacturing.

Read more on MRVI →

About VF Corp

VF designs, produces, and distributes branded apparel and accessories. Its largest apparel categories include action sports, outdoor, and workwear. Its portfolio of about a dozen brands includes Vans, The North Face, Timberland, Supreme, and Dickies. VF markets its products in the Americas, Europe, and Asia-Pacific through wholesale sales to retailers, e-commerce, and branded stores owned by the company and partners. The company has grown through multiple acquisitions and traces its roots to 1899.

Read more on VFC →